Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Deloitte
Federal Trade Commission
US Department of Justice
Citi
Cerilliant
Moodys
Chubb
Chinese Patent Office

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022404

« Back to Dashboard

NDA 022404 describes ORAVIG, which is a drug marketed by Midatech Pharma Us and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the ORAVIG profile page.

The generic ingredient in ORAVIG is miconazole. There are twenty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the miconazole profile page.
Summary for 022404
Tradename:ORAVIG
Applicant:Midatech Pharma Us
Ingredient:miconazole
Patents:3
Formulation / Manufacturing:see details
Pharmacology for NDA: 022404
Ingredient-typeAzoles
Suppliers and Packaging for NDA: 022404
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ORAVIG miconazole TABLET;BUCCAL 022404 NDA Midatech Pharma US, Inc. 89141-250 N 89141-250-02
ORAVIG miconazole TABLET;BUCCAL 022404 NDA Midatech Pharma US, Inc. 89141-250 N 89141-250-14

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;BUCCALStrength50MG
Approval Date:Apr 16, 2010TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Sep 11, 2022Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF OROPHARYNGEAL CANDIDIASIS
Patent:➤ Sign UpPatent Expiration:Sep 11, 2022Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF OROPHARYNGEAL CANDIDIASIS
Patent:➤ Sign UpPatent Expiration:Sep 11, 2022Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Chubb
Dow
Baxter
McKesson
Cantor Fitzgerald
US Department of Justice
Mallinckrodt
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.